drugset / Trial / NCT01916642

A Dose-response Study of Lidocaine and Etomidate

NCT01916642

Phase 1 Completed 100 enrolled West China Hospital
RandomizedParallel-groupDouble-blindSupportive care

Summary

IV lidocaine administration can reduce the minimal amount of Etomidate and time for induction of anesthesia.

Timeline

Start
2013-04
Primary completion
2013-06
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 1 mg/kg Intravenous
Comparator Lidocaine Other / unclassified 1.5 mg/kg Intravenous
Comparator Lidocaine Other / unclassified 2 mg/kg Intravenous
Comparator Lidocaine Other / unclassified 2.5 mg/kg Intravenous

Indications

No indication recorded.